Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442) [Phase 4]

View source ↗

Summary

Phase 4 trial update on nasal symptom relief and side effects in hayfever patients treated with desloratadine (Aerius).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aerius (cetirizine)

Snippet

Sponsor: Organon and Co | Conditions: Rhinitis, Allergic, Seasonal | Phase 4 | Status: COMPLETED